[Federal Register Volume 78, Number 223 (Tuesday, November 19, 2013)]
[Notices]
[Pages 69417-69418]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-27653]
[[Page 69417]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-14-14CL]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570 or
send comments to LeRoy Richardson, 1600 Clifton Road, MS-D74, Atlanta,
GA 30333 or send an email to [email protected].
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
An Investigation of Lung Health at an Indium-Tin Oxide Production
Facility--New--National Institute for Occupational Safety and Health
(NIOSH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The mission of the National Institute for Occupational Safety and
Health (NIOSH) is to promote safety and health at work for all people
through research and prevention. The Occupational Safety and Health
Act, Public Law 91-596 (section 20[a] [1]), authorizes NIOSH to conduct
research to advance the health and safety of workers. NIOSH is
proposing to conduct a study regarding the lung health of workers at an
indium-tin oxide production facility.
Indium-tin oxide (ITO) is a sintered material used in the
manufacture of devices such as liquid crystal displays, touch panels,
solar cells, and architectural glass. Indium lung disease is a novel,
potentially fatal industrial disease that has occurred in workers
making, using, or recycling ITO. This project aims to understand and
prevent this occupational lung disease by investigating the
relationship between exposure and lung health among current ITO
manufacturing workers.
CDC requests Office of Management and Budget (OMB) approval to
collect standardized information from current employees of the ITO
production facility through an informed consent document, an
interviewer-administered questionnaire, and a contact information form.
As part of the same project, employees will be offered the opportunity
to participate in medical testing and personal air sampling.
The questionnaire will collect contact information, demographic
information, respiratory symptoms and diagnoses, work history, and
cigarette smoking history. The questionnaire will allow NIOSH to report
individual medical test results to each participant and to analyze
aggregate data from the workforce to determine risk factors for
abnormal lung health indices derived from the medical test results. The
individual results will be used by employees and their personal
physicians to make medical decisions, such as whether to pursue
additional testing. The aggregate results will be used by NIOSH,
facility management, and employees in ongoing efforts to reduce
exposures and monitor key health indices.
For this study, we will recruit all current employees of the ITO
production facility. Participation is voluntary. Employees who wish to
participate in the questionnaire and medical testing will review and
sign an informed consent document. Employees who wish to participate in
the personal air sampling and would like to receive personal results
will complete a contact information form. We anticipate approximately
100 study participants. The questionnaire will be administered
privately at the workplace during normal working hours by trained NIOSH
staff. Employees who are not available at the workplace during the
study will be offered the opportunity to respond to the questionnaire
at a later date by telephone. There are no costs to participants other
than their time.
The total estimated burden for the one-time collection of data is
66 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Current ITO production Informed consent 100 1 15/60 25
facility employees. document.
Questionnaire... 100 1 20/60 33
Contact 100 1 5/60 8
information
form.
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 66
----------------------------------------------------------------------------------------------------------------
[[Page 69418]]
LeRoy Richardson,
Chief, Office of Scientific Integrity, Office of the Associate Director
for Science, Office of the Director, Centers for Disease Control and
Prevention.
[FR Doc. 2013-27653 Filed 11-18-13; 8:45 am]
BILLING CODE 4163-18-P